MedPath

A study to evaluate safety and performance of Hydroxypropyl Methylcellulose Eye Drops

Phase 4
Conditions
Health Condition 1: PCS-
Registration Number
CTRI/2024/06/069121
Lead Sponsor
Kilitch Healthcare India Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects who are able to give voluntary, written informed consent to participate in this study.

Subjects who experience eye dryness, eye soreness/ burning, irritative sensation and discomfort

of eyes due to the continuous use of computer/ TV/ exposed pollution/ dry environment.

Exclusion Criteria

Anyone with known allergic reaction to Hydroxypropyl Methylcellulose Eye Drops.

Subjects with existing eye infection.

History of ocular surgery. History or active signs of severe or serious ocular conditions such as inflammatory corneal ulcers, recurrent erosions, and uveitis at any time.

Patients participating in any another clinical trial during study.

Pregnant/lactating women during study period.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath